Maky Zanganeh

About Maky Zanganeh

Maky Zanganeh is co-CEO of Summit Therapeutics, a biotech firm with a promising drug candidate to treat lung cancer. She owns just under 5% of the company's stock.

Zanganeh, an immigrant from Iran, previously served as chief operating officer of drug firm Pharmacyclics, which was acquired by AbbVie for $21 million in 2015.

Zanganeh first came to the U.S. to work for robotic surgery firm Computer Motion in 2002 after running the company's European operations.

Zanganeh runs Summit Therapeutics as co-CEO with Robert (Bob) Duggan, who became a billionaire after investing in and running Pharmacyclics. She and Duggan married in 2024.

She trained as a dentist at university in Strasbourg, France and then obtained an MBA while first working at Computer Motion.